Hepatitis
Guidelines
AASLD: Liver transplants should proceed despite COVID-19
Immunosuppression may be protective; the advice comes from a document a recently released from AASLD to help hepatologists and liver transplant...
From the Journals
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
Conference Coverage
Stick with the full 12-week DAA course for acute HCV
From the Journals
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.
Latest News
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
An estimated one in three inmates in the United States has chronic HCV.
Conference Coverage
HBV: Rethink the free pass for immune tolerant patients
MAUI, HAWAII – Not treating means more liver cancer.
From the Journals
HBV: Surface antigen titer and ALT predict seroconversion
In patients with hepatitis B virus infection, surface antigen titer and alanine aminotransferase level may independently predict spontaneous...
From the Journals
Occult HCV infection is correlated to unfavorable genotypes in hemophilia patients
Unfavorable interferon gentoypes were correlated to occult HCV infection in paitents with hemophilia.
Latest News
HCV a risk in HIV-negative MSM who use PrEP
HIV-negative MSM on PrEP are at risk for HCV-infection, with risk-factors similar to those in HIV-positive MSM.
From the Journals
Long-term entecavir looks safe, effective in HBV
The entecavir and nonentecavir trial arms did not significantly differ in time-to-event analyses of malignant neoplasms, liver-related HBV disease...
Conference Coverage
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy,...